Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?

Chronic hepatitis B (CHB) remains a challenging global health problem, with nearly one million related deaths per year. Nucleos(t)ide analogue (NA) treatment suppresses viral replication but does not provide complete cure of the hepatitis B virus (HBV) infection. The accepted endpoint for therapy is...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno-Cubero, Elia, del Arco, Robert T Sánchez, Peña-Asensio, Julia, de Villalobos, Eduardo Sanz, Míquel, Joaquín, Larrubia, Juan Ramón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937201/
https://www.ncbi.nlm.nih.gov/pubmed/29740199
http://dx.doi.org/10.3748/wjg.v24.i17.1825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937201/
https://www.ncbi.nlm.nih.gov/pubmed/29740199
http://dx.doi.org/10.3748/wjg.v24.i17.1825

Ejemplares similares